Brief: Arix Bioscience Says Portfolio Co Imara Announces Merger Deal With Enliven Therapeutics
14/10/2022 07:18
Oct 14 (Reuters) - Arix Bioscience PLC ARIX.L :
* REG-ARIX BIOSCIENCE PLC PORTFOLIO COMPANY IMARA ANNOUNCES
MERGER
AGREEMENT WITH ENLIVEN THERAPEUTICS
* ARIX BIOSCIENCE PLC - PORTFOLIO COMPANY IMARA ANNOUNCES
MERGER
AGREEMENT WITH ENLIVEN THERAPEUTICS
* ARIX BIOSCIENCE PLC - TRANSACTION TO CONCURRENTLY RAISE
ABOUT
$165 MILLION IN A PRIVATE FINANCING
Source text for Eikon: ID:nEQ13Mznga
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment